Canada markets closed

Entheon Biomedical Corp. (1XU.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.0835-0.0085 (-9.24%)
At close: 07:30PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-11-30
2021-11-30
2020-11-30
2020-03-31
Total Revenue
370.323
189.677
0
0
0
Cost of Revenue
-
-
12.54
0
-
Gross Profit
-
-
9.13
0
-
Operating Expenses
Research Development
2.39
1,199
1,212
442.56
-
Selling General and Administrative
838.277
2,589
6,998
3,931
144.514
Total Operating Expenses
841.591
3,790
8,215
4,377
144.514
Operating Income or Loss
-471.268
-3,600
-8,215
-4,377
-144.514
Interest Expense
0
-
-
-
0
Total Other Income/Expenses Net
0.176
1,538
205.452
-12.275
-22.271
Income Before Tax
-470.336
-2,061
-7,999
-4,381
-146.783
Income Tax Expense
0
-
-
-
0
Income from Continuing Operations
-470.336
-2,061
-7,999
-4,381
-146.783
Net Income
-6,068
-8,521
-8,887
-4,381
-146.783
Net Income available to common shareholders
-6,068
-8,521
-8,887
-4,381
-146.783
Basic EPS
-0.11
-1.44
-0.16
-0.16
-0.02
Diluted EPS
-0.11
-1.44
-0.16
-0.16
-0.02
Basic Average Shares
59,089
59,089
54,285
27,440
6,035
Diluted Average Shares
59,089
59,089
54,285
27,440
6,035